BUSINESS & RESEARCH DEVELOPMENT…

BUSINESS DEVELOPMENT

MIDPHARMA is a multi-specialty branded-generics company, offering the generics industry a complete service range from product development and registration through to sourcing, manufacturing, packaging and logistics.

MIDPHARMA’s Business Development identifies market opportunities based on marketing analysis and forthcoming patent expiries, develops pharmaceutical formulations, advances projects to market approval stage, and assembles complete drug regulatory dossiers and licenses to be registered in countries where MIDPHARMA is active.

Apart from having a healthy pipeline for the generics, MIDPHARMA was one of the first manufacturers in Jordan to produce under license a biotechnology product which is the Recombinant Human Erythropoietin Epokine.

Additionally, we produce under a contract manufacturing agreement for various multinational companies.

RESEARCH & DEVELOPMENT

MIDPHARMA nurtures a culture for innovation and development, it is highly dependant on the support of it’s R&D to test and develop new formulations.

Generic pharmaceuticals are the bioequivalent of an originator, brand name product. This includes dosage forms, safety, strengths, routes of administration, quality, performance characteristics and intended use. MIDPHARMA’s generics are held to the same strict standards as the originator product, dictated by the U.S. Food and Drug Administration (FDA), Jordanian FDA, and other regulatory organizations throughout the world.

Our highly qualified R&D staff is supported by the latest equipment work to research our pipeline products, test the new formulations, and conduct all the required stability and biological studies .